What's up in

Interviews & Opinions

QnA

Ducking Nonsense: Why Sensible Leadership And Real Learning Matter In Pharma: Mr. Santosh Dayal

FT - Santosh Dayal | December 29, 2025 |

QnA

From Biosimilars to Cell & Gene Therapy: Career Lessons from Kodo Lifesciences’ Dr. Ravish Patel

FT - Dr. Ravish Patel | November 19, 2025 |

QnA

Dr. Paul Faulder, the CEO Behind Pharma R&D’s Digital Transformation | Elixir Software

FT - Dr. Paul Faulder | November 1, 2025 |

QnA

Inside Bioprocessing: Dr. Patra on Biosimilars & Leadership

FT - Dr. Ashok Kumar Patra | September 17, 2025 |

QnA

How Mukesh Patale Builds Biologics: Upstream Tricks, AI & Team Leadership

FT - Mukesh Patale | September 10, 2025 |

QnA

Evolving Pharma Inspections: Hybrid Audit Insights from Parexel Veteran Dr. Siegfried Schmitt

FT - Dr. Siegfried Schmitt | September 6, 2025 |

Dr. Siegfried Schmitt unpacks hybrid audits, pallet contamination risks, and the future of pharma lo...

QnA

Why Lextro Bio Might Be India’s Next Big Biotech Breakthrough

FT - Dr. Murali K. Addepalli | August 23, 2025 |

Exclusive interview with Dr. Murali on his biotech journey, organoids, and Lextro Labs’ mission to t...

QnA

The Scientist Behind Emcure Pharma's API Success: Dr. Abhijit Roychowdhury

FT - Dr. Abhijit Roychowdhury | August 21, 2025 |

Dr. Abhijit Roychowdhury reveals his journey building Emcure’s API R&D and shaping innovation in Ind...

QnA

Pharma Warning Letters Explained by Ipca’s Regulatory Affairs Head

FT - Dr. Shuvankar Ballav | August 9, 2025 |

Dr. Ballav of Ipca Laboratories shares insights on regulatory strategy, biosimilars, audits, AI, and...